Infinite Roots, formerly Mushlabs, a leading German biotech company, announced the closing of its €53 million Series B funding round. The oversubscribed funding round represents the largest investment in mycelium technologies in Europe to date and underlines the growing importance of mycelium in the global food system.

Source: Hamburg-based biotech Infinite Roots bags €53 million Series B to mushroom up production | EU-Startups